Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Post by runningonemptyon Mar 21, 2015 1:57pm
252 Views
Post# 23547083

Prospectus

Prospectus
Does this not mean the filing of the $50m shelf prospectus  can be used over the next 25 months as the company requires funds? This does not mean the company will use all of the prospectus right away but gives them the flexibility as they see fit, if needed. The company has said they have enough cash on hand until Q4 2015. By filing this, it takes away any major cash concerns over the remainder of the year and beyond. Depending on how much they decide to exercise, does this not give them a better position to deal with potential partners, buyouts or going it alone?
I think doing this prospectus it better than a full blown financing, this allows greater flexibility.
Hopefully the company does the right thing for shareholders and this prospectus gets the ball rolling to completion. We have endeared many things over the past years, hopefully we can get this to the finish line and everyone wins.
Does anyone know if the $1.25 Euro Pacific target included any future financing or was it based on current shares outstanding?
<< Previous
Bullboard Posts
Next >>